Clinical trials
Observational Fatigue Syndrome, Chronic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 5 |
| Enrolling by invitation | 3 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Mental Health (NIMH) | 2 |
| New York CFS Association | 2 |
| ProgenaBiome | 2 |
| Stony Brook University | 2 |
| Brain Inflammation Collaborative | 1 |
| Columbia University | 1 |
| DxTerity Diagnostics | 1 |
| Georgetown University | 1 |
| Johns Hopkins University | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatigue Syndrome, Chronic | 26 |
| Fibromyalgia | 8 |
| Irritable Bowel Syndrome | 5 |
| Anxiety Disorders | 4 |
| Fatigue | 4 |
| Arthritis, Rheumatoid | 3 |
| Colitis, Ulcerative | 3 |
| Crohn Disease | 3 |
| Migraine Disorders | 3 |
| Multiple Sclerosis | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.